| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Lai,Qiu-Yu | Chairman | 6.41% | |
| Liu,Yi-Qi | Managing Director | 0.72% | |
| Xie,Zhao-Sheng | Managing Director | 0.47% | |
| Wu,Wen-Cheng | Managing Director | 0.70% | |
| Lai,Chun-Lin | Managing Director | 0.55% | |
| Wu,Wen-Qing | Director | 0.81% | |
| Vacancy | Director | ||
| Huang,Li-Zhen | Director | 3.38% | |
| Wu,Jun-Ming | Director | 2.98% | |
| Lai,Qiu-Hong | Director | 0.68% | |
| Chen,Yin-Ru | Director | 1.14% | |
| Chen,Li-Ling | Director | 0.29% | |
| Wei,Pei-Zhen | Director | 0.35% | |
| Chen,Qi-Ming | Director | 0.45% | |
| Guo,Wen-Cong | Director | 0.39% | |
| Chen,Si-Ying | Supervisor | 0.77% | |
| Wei,Shi-Xun | Supervisor | 0.77% | |
| Lin,Jin-Yong | Supervisor | 0.62% |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating income | 436,274 | 781,195 | 768,004 |
| Operating cost | 337,889 | 623,792 | 616,490 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 98,385 | 157,403 | 151,514 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 98,385 | 157,403 | 151,514 |
| Operating expenses | 28,858 | 57,036 | 55,398 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | 69,527 | 100,367 | 96,116 |
| Non-operating income and expenses | 10,544 | 31,034 | 29,219 |
| Net profit (loss) before tax | 80,071 | 131,401 | 125,335 |
| Income tax expense (benefits) | 16,014 | 24,558 | 23,336 |
| Net profit (loss) of ongoing business for the current period | 64,057 | 106,843 | 101,999 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | 64,057 | 106,843 | 101,999 |
| Other comprehensive profit (loss), net | -4,765 | 18,765 | 15,056 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 59,292 | 125,608 | 117,055 |
| Net profit (loss) attributable to owners of parent company | - | - | - |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | - | - | - |
| Comprehensive profit (loss) attributable to owners of parent company | - | - | - |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
| Basic earnings per share (yuan) | 0 | 1 | 1 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | - | - | - |
| Net cash inflows (outflows) from investing activities | - | - | - |
| Net cash inflow (outflow) from financing activities | - | - | - |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - | - |
| Increase (decrease) in cash and cash equivalents in the current period | - | - | - |
| Beginning balance of cash and cash equivalents | - | - | - |
| Ending balance of cash and cash equivalents | - | - | - |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current asset | 895,347 | 846,938 | 830,958 |
| Non-current asset | 2,073,731 | 2,033,718 | 1,936,899 |
| Total asset | 2,969,078 | 2,880,656 | 2,767,857 |
| Current liability | 726,464 | 599,797 | 506,094 |
| Non-current liability | 612,348 | 613,153 | 626,653 |
| Total liability | 1,338,812 | 1,212,950 | 1,132,747 |
| share capital | 744,094 | 744,094 | 744,094 |
| Equity - secruity token | - | - | - |
| capital reserve | 29 | 29 | 29 |
| retained earning | 683,526 | 716,201 | 702,665 |
| Other equity | 202,617 | 207,382 | 188,322 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | - | - | - |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | - | - | - |
| Total Equity | 1,630,266 | 1,667,706 | 1,635,110 |
| Share capital awaiting retirement (unit: share) | - | - | - |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 21 | 22 | 21 |
